Focal Laser Ablation in Prostate Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age45+
SponsorAin Shams University
About this trial
To assess the effectiveness of MRI-US or PSMA PET/CT-U/S fusion-guided focal laser ablation (FLA) for the treatment of a localized, intermediate-risk prostate cancer in terms of short-term oncological \& functional outcomes.
Eligibility criteria
Qualifiers
Prostate cancer visible on mpMRI or PSMA PET/CT and positive in the targeted biopsy.
Gleason score 7 (ISUP grade 2/3)
PSA 10-20 ng/mL
Clinical stage T2b
Disqualifiers
Prostate cancer invisible on mpMRI or PSMA PET/CT but positive in the systematic biopsies.
Presence of >2 MRI-visible lesions and positive in the biopsies.
Extracapsular extension
Seminal vesicle invasion
Trial design
Treatments tested in this trial
- Focal laser ablation
- Focal laser ablation
Treatment groups
30 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov